Molotinib dosage, side effects, precautions

Molotinib is a new drug designed to treat moderate or high-risk myelofibrosis, a disease that affects the blood-forming function of the bone marrow. Molotinib provides a new treatment strategy for these patients through its unique mechanism.

Regarding the dosage of molotinib, the recommended starting dose is usually 200 mg per day It can be taken orally and can be taken with food to reduce gastrointestinal discomfort. Patients should swallow the medication whole and avoid cutting or chewing. For patients with severe hepatic impairment, the recommended starting dose should be adjusted to 150 mg per day.

However, like other drugs, molotinib may cause some side effects. Common ones include thrombocytopenia, bleeding, bacterial infection, fatigue, dizziness, diarrhea and nausea. Most of these reactions are mild to moderate and may gradually lessen during treatment. However, if severe or persistent side effects occur, patients should consult their doctor immediately.

There are some important considerations to keep in mind when using molotinib. First, patients with active infection should be carefully evaluated before starting treatment and continuously monitored for signs of infection during treatment. Secondly, since molotinib is mainly metabolized in the liver, liver function should be checked regularly to ensure the effectiveness and safety of the drug. In addition, pregnant and breastfeeding women should specifically consult their doctor before use, as it is unknown whether this drug may affect the fetus or newborn.

Overall, molotinib provides a new treatment option for patients with intermediate or high-risk myelofibrosis. When using it, patients should strictly follow the doctor's instructions and pay attention to observe and report any discomfort or abnormal reactions to ensure the safety and effectiveness of the treatment. Through rational medication use and close doctor-patient communication, molotinib is expected to bring better quality of life and disease control effects to patients.